Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cognis sets up Indian subsidiary

This article was originally published in Scrip

Executive Summary

Cognis has set up a wholly-owned subsidiary, Cognis Specialty Chemicals, in Mumbai. Cognis, which first opened a liaison office in India in February last year, expects the new affiliate to continue to grow its business in the country. Last year Cognis' sales in India grew by about 30%. The company supplies innovative ingredients for products such as pharmaceuticals, personal and home care, food ingredients and dietary supplements and has been increasingly allocating resources to its operations in the Asia-Pacific region. This is now its third-biggest market after Europe and North America. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts